Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All curcumin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchCurcuminCurcumin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Viral clearance, day 10 53% Improvement Relative Risk Viral clearance, day 14 75% Viral clearance, day 21 67% Curcumin  Hartono et al.  LATE TREATMENT  RCT Is late treatment with curcumin + virgin coconut oil beneficial for COVID-19? RCT 60 patients in Indonesia (May - September 2020) Improved viral clearance with curcumin + virgin coconut oil (p=0.0000019) c19early.org Hartono et al., Pharmacognosy J., February 2022 Favors curcumin Favors control

The Effect of Curcumin and Virgin Coconut Oil Towards Cytokines Levels in COVID-19 Patients at Universitas Sebelas Maret Hospital, Surakarta, Indonesia

Hartono et al., Pharmacognosy Journal, doi:10.5530/pj.2022.14.27
Feb 2022  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Curcumin for COVID-19
14th treatment shown to reduce risk in February 2021
 
*, now known with p = 0.000000046 from 26 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
RCT with 30 patients treated with curcumin and virgin coconut oil (VCO), and 30 SOC patients in Indonesia, showing faster viral clearance with treatment. Treatment also reduced IL-1β, IL-2, IL-6, IL-18, and IFN-β levels. VCO improves the bioavailability of curcumin. There were large unadjusted differences in baseline severity and age, for example 20% vs. 47% of patients >50. VCO 30ml and curcumin 1g tid for 21 days. 066/UN27.06.6.1/KEPK/EC/2020.
This is the 9th of 20 COVID-19 RCTs for curcumin, which collectively show efficacy with p=0.0000093.
This is the 13th of 26 COVID-19 controlled studies for curcumin, which collectively show efficacy with p=0.000000046 (1 in 22 million).
This study is excluded in the after exclusion results of meta analysis: randomization resulted in significant baseline differences that were not adjusted for.
risk of no viral clearance, 53.3% lower, RR 0.47, p < 0.001, treatment 14 of 30 (46.7%), control 30 of 30 (100.0%), NNT 1.9, day 10.
risk of no viral clearance, 75.0% lower, RR 0.25, p = 0.002, treatment 4 of 30 (13.3%), control 16 of 30 (53.3%), NNT 2.5, day 14.
risk of no viral clearance, 66.7% lower, RR 0.33, p = 1.00, treatment 0 of 30 (0.0%), control 1 of 30 (3.3%), NNT 30, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), day 21.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Hartono et al., 22 Feb 2022, Randomized Controlled Trial, Indonesia, peer-reviewed, 13 authors, study period May 2020 - September 2020, this trial uses multiple treatments in the treatment arm (combined with virgin coconut oil) - results of individual treatments may vary.
This PaperCurcuminAll
The Effect of Curcumin and Virgin Coconut Oil Towards Cytokines Levels in COVID-19 Patients at Universitas Sebelas Maret Hospital, Surakarta, Indonesia
Hartono Hartono, B Suryawati, Y Sari, A Avicena, Maryani Maryani, C Sukmagautama, H Apriningsih, L Shofiyah, Rgh Novika, N J Wahidah, N Y Rahmawati, Anm Ansori, L Sumarno
Pharmacognosy Journal, doi:10.5530/pj.2022.14.27
Coronavirus Disease 2019 (COVID-19) is a respiratory disease reported to have emerged in late December 2019 in Wuhan, China. It causes by a novel coronavirus known as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). COVID-19 has grown rapidly and was declared a pandemic by WHO. 1 In patients with severe MERS, serum cytokine and chemokine levels are significantly higher than those in patients with mild to moderate MERS.
DISCLOSURE STATEMENT The authors have no conflicts of interest to declare. AUTHOR CONTRIBUTION H ABOUT AUTHORS
References
Abrahams, Haylett, Johnson, Carr, Bardien, Antioxidant effects of curcumin in models of neuro degeneration, aging, oxidative and nitrosative stress: A review, Neuroscience
Ansori, Kharisma, Muttaqin, Antonius, Parikesit, Genetic variant of SARS-CoV-2 isolates in Indonesia: Spike glycoprotein gene, J Pure Appl Microbiol
Avasarala, Zhang, Liu, Wang, London et al., Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome, PLoS One
Barnard, Kumaki, Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy, Pharmacognosy Journal
Bosi, Bosi, Querini, Mancini, Calori et al., Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): Study protocol for a randomized controlled trial, Trials
Channappanavar, Perlman, Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology, Semin Immunopathol
Chen, Lee, Chuang, Li, Ning et al., Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT, Int J Mol Med
Danthi, Viruses and the diversity of cell death, Annu Rev Virol
Dong, Cao, Lu, Zhang, Du et al., Eleven faces of coronavirus disease 2019, Allergy
Dr, Sumarno, Si, was graduated from the Faculty of Chemical Engineering
Han, Xu, Guo, Huang, Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production, Clin Exp Pharmacol Physiol
Hartono, Sari, Novika, Avicena, Maryani, The Effect of Curcumin and Virgin Coconut Oil Towards Cytokines Levels in COVID-19 Patients at Universitas Sebelas Maret Hospital, Surakarta, Indonesia, Pharmacogn J
Hartono, The Effect of Curcumin and Virgin Coconut Oil Towards Cytokines Levels in COVID-19 Patients at Universitas Sebelas Maret Hospital
Hartono, involved in Indonesia-National Adolescent Mental Health Survey by Universitas Gadjah Mada -John Hopkins University and in Clinical trial research on the effect of ethanol extract of gendarussa capsules as male nonhormonal contraceptives
Hima, Pratap, Karrunanithi, Ravichandran, Vasantharekha et al., Virgin coconut oil supplementation in diet modulates immunity mediated through survival signaling pathways in rats, J Complement Integr Med
Hussain, Tan, Yin, Blachier, Tossou et al., Oxidative stress and inflammation: What polyphenols can do for us?, Oxid Med Cell Longev
Intahphuak, Khonsung, Panthong, Anti-inflammatory, analgesic, and antipyretic activities of virgin coconut oil, Pharm Biol
Kharisma, Ansori, Widyananda, Rizky, Dings, Herbal combination from Moringa oleifera Lam. and Curcuma longa L. as SARS-CoV-2 antiviral via dual inhibitor pathway: A viroinformatics approach, J Pharm Pharmacogn Res
Khedir, Mzid, Bardaa, Moalla, Sahnoun et al., In vivo evaluation of the anti-inflammatory effect of Pistacia lentiscus fruit oil and its effects on oxidative stress, Evid Based Complement Alternat Med
Kim, Oh, Kim, Activation of the Nrf2/HO-1 pathway by curcumin inhibits oxidative stress in human nasal fibroblast exposed to urban particulate matter, BMC Compl Med Ther
Lai, Yan, Liao, Li, Ye et al., 3D-quantitative structureactivity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase, Arch Pharm Res
Liau, Lee, Chen, Rassol, An open-label pilot study to assess the efficacy safety of VCO in reducing visceral adiposity, ISRN Pharmacol
Lin, Luo, Qin, Yang, Wang et al., Long-term infection of SARS-CoV-2 changed the body's immune status, Clin Immunol
Luo, Zhang, Xu, Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19), Clin Gastroenterol Hepatol
Nur, Ansori, Si, Si, is a doctoral candidate in veterinary science at Universitas Airlangga, Indonesia
Pacheo, Faria, The potential involvment of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target?, Scand J Immunol
Peter, Calming the storm: natural immunosupressants as adjuvants to target the cytokine storm ini COVID-19, Front in pharmacology
Pivari, Mingione, Brasacchio, Soldati, Curcumin and type 2 diabetes mellitus: Prevention and treatment, Nutrients
Ragab, Eldin, Taeimah, Salem, The covid-19 cytokine storm; what we know so far, Front. immunology
Ragab, Salah Eldin, Taeimah, Khattab, Salem, The COVID-19 cytokine storm; what we know so far, Front Immunol
Shirey, Blanco, Vogel, Targeting TLR4 signaling to blunt viral-mediated acute lung injury, Front Immunol
Soni, Mehta, Ratre, Tiwari, Amit, Curcumin, a traditional spice component, can hold the promise against COVID-19?, Eur J Pharmacol
Tanaka, Narazaki, Kishimoto, IL-6 in Inflammation, immunity, and disease
Tang, Liu, Zhang, Xu, Wen, Cytokine storm in COVID-19: The current evidence and treatment strategies, Front Immunol
Vysakh, Ratheesh, Rajmohanan, Pramod, Premlal et al., Polyphenolics isolated from virgin coconut oil inhibits adjuvant induced arthritis in rats through antioxidant and anti-inflammatory action, Int Immunopharmacol
Wong, Lam, Wu, Ip, Lee et al., Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clin Exp Immunol
Xu, Liu, Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-κB signaling pathway, Influenza Other Respir Viruses
Yao, Sun, Song, Protective effects of dioscin against lipopolysaccharide-induced acute lung injury through inhibition of oxidative stress and inflammation, Front Pharmacol
Ye, Wang, Mao, The Pathogenesis and treatment of the cytokine storm in Covid-19, Journal of infection
Yeap, Beh, Ali, Yusof, Ho et al., Anti stress and antioxidant effects of virgin coconut oil in vivo, Exp Ther Med
Yedjou, Njiki, Enow, Ikome, Latinwo et al., Pharmacological effects of selected medicinal plants and vitamins against COVID-19, J Food Nutr
Yin, Guo, Li, Tang, Li et al., Curcumin suppresses IL-1β secretion and prevents inflammation through inhibition of the NLRP3 inflammasome, J Immunol
Youm, Nguyen, Grant, Goldberg, Kim et al., The ketone metaboliteβ-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease, Nat. Med
Yuli Rahmawati, Si, Sc, is a doctoral candidate in medical sciences at the Faculty of Medicine
Zentek, Buchheit-Renko, Ferrara, Vahjen, Kessel et al., Nutritional and physiological role of medium-chain triglycerides and medium-chain fatty acids in piglets, Anim Health Res Rev
Zuccotti, Trabattoni, Morelli, Borgonovo, Schneider et al., Immune modulation by lactoferrin and curcumin in children with recurrent respiratory infections, J Biol Regul Homeost Agents
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit